Home / Sweden / Active Biotech AB (publ)
Active Biotech AB (publ)
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
22 disclosures on record
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
January 19, 2021 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| December 22, 2025 | Guevoura Fund | 1.25% | still open |
| December 17, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.30% | still open |
| December 16, 2025 | Guevoura Fund | 2.68% | still open |
| December 16, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.23% | still open |
| December 15, 2025 | Guevoura Fund | 2.59% | still open |
| December 15, 2025 | Millennium Capital Management (Hong Kong) Limited | 1.11% | still open |
| December 12, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.99% | still open |
| December 11, 2025 | Guevoura Fund | 2.42% | still open |
| December 11, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.74% | still open |
| December 10, 2025 | Guevoura Fund | 2.40% | still open |
| December 10, 2025 | Millennium Capital Management (Hong Kong) Limited | 0.58% | still open |
| December 9, 2025 | Guevoura Fund | 2.05% | still open |
| December 3, 2025 | Guevoura Fund | 1.36% | still open |
| November 28, 2025 | Guevoura Fund | 0.90% | still open |
| November 27, 2025 | Guevoura Fund | 0.67% | still open |
| February 12, 2021 | Guevoura Fund | 0.00% | still open |
| February 4, 2021 | Guevoura Fund | 0.94% | still open |
| February 2, 2021 | Guevoura Fund | 0.82% | still open |
| January 29, 2021 | Guevoura Fund | 1.14% | still open |
| January 28, 2021 | Guevoura Fund | 0.96% | still open |
| January 26, 2021 | Guevoura Fund | 0.63% | still open |
| January 19, 2021 | Guevoura Fund | 0.50% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.58% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Active Biotech AB (publ), source Finansinspektionen, data as at December 22, 2025, https://www.quivad.com/action/active-biotech-ab-publ